Last 9,330 KRW
Change Today +320.00 / 3.55%
Volume 137.6K
As of 2:19 AM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

bioneer corp (064550) Snapshot

Open
9,130
Previous Close
9,010
Day High
9,430
Day Low
9,000
52 Week High
04/2/14 - 17,500
52 Week Low
07/31/14 - 6,950
Market Cap
128.6B
Average Volume 10 Days
333.2K
EPS TTM
-565.00
Shares Outstanding
13.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BIONEER CORP (064550)

Related News

No related news articles were found.

bioneer corp (064550) Related Businessweek News

No Related Businessweek News Found

bioneer corp (064550) Details

Bioneer Corporation, a biotechnology company, engages in the development and manufacture of molecular biology products and technologies in South Korea. The company offers synthetic DNA/RNA oligonucleotides; DNA/RNA extraction and purification kits; DNA/RNA synthesis reagents, such as DNA and RNA phosphoramidites, modified phosphoramidites, and controlled pore glasses for oligo synthesis; gene synthesis, mutagenesis, and gene cloning services; AccuGeneBlock service, which includes the synthesis of double strand DNA fragments; gene expression profiling services; and RNA interference technology products. It also provides a range of enzymes for PCR, reverse transcription, reverse transcriptase PCR, and DNA ligation; protein expression and purification instrumentation and kits; DNA ladders and molecular weight markers; S. pombe genome-wide deletion mutant library for protein-protein interaction analysis; genomics synthesis and sequencing services; drug target and toxicity identification services; buffers and manual sequencing kits; plastic consumables; and instruments for protein synthesis, PCR, sample preparation, centrifuge and vortex mixing, and electrophoresis. In addition, the company offers molecular diagnostics products, which include platform technologies that integrate reagents and instruments; MDx instruments; and human and veterinary diagnostics kits. Further, it engages in the development of drugs in the areas of cancer, COPD, liver fibrosis, and antivirals through its self-assembled-micelle-inhibitory-RNA prodrug platform technology. Bioneer Corporation was founded in 1992 and is headquartered in Daejeon, South Korea.

Founded in 1992

bioneer corp (064550) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

bioneer corp (064550) Key Developments

Bioneer Corporation Presents at HSBC 5th Annual Asia Investor Forum - Boston, Nov-20-2013

Bioneer Corporation Presents at HSBC 5th Annual Asia Investor Forum - Boston, Nov-20-2013 . Venue: The Boston Harbor Hotel, 70 Rowes Wharf, Boston, MA 02110, United States.

Bioneer Corporation Presents at HSBC 5th Annual Asia Investor Forum - New York, Nov-18-2013

Bioneer Corporation Presents at HSBC 5th Annual Asia Investor Forum - New York, Nov-18-2013 . Venue: New York Palace Hotel, 455 Madison Avenue at 50th Street, New York, NY 10022, United States.

Bioneer Corporation, Annual General Meeting, Mar 21, 2013

Bioneer Corporation, Annual General Meeting, Mar 21, 2013., at 10:30 Korea Standard Time. Location: 8-11, Bioneer seminar rooms. Agenda: To approve consolidated financial statements for the year ended December 31, 2012; to appoint of inside directors; to approve of directors' remuneration limit; to approve of the audit fees; and to approve other references concerning investment decisions.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
064550:KS 9,330.00 KRW +320.00

064550 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 064550.
View Industry Companies
 

Industry Analysis

064550

Industry Average

Valuation 064550 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.2x
Price/Book 3.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIONEER CORP, please visit www.bioneer.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.